by Dale Harrison | Oct 14, 2022 | Events
October 19, 2022 bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference Powerful platform reveals the lung environment for diagnosing lung diseases Research Scientist Lydia Bederka, PhD, will present results of the...
by Dale Harrison | Oct 12, 2022 | Press Releases
Powerful platform reveals the lung environment for diagnosing lung diseases SAN ANTONIO, TX – Oct. 12, 2022 – bioAffinity Technologies, Inc., (NASDAQ: BIAF; BIAFW) will present results of its research into the use of flow cytometry for analyzing the lung environment...
by Dale Harrison | Sep 30, 2022 | Articles, News
Behind the Deal: Company’s decision to go public drawing capital and attention to SA SEPTEMBER 30, 2022 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal The move by bioAffinity Technologies Inc. to...
by Dale Harrison | Sep 14, 2022 | Press Releases
SAN ANTONIO–(BUSINESS WIRE)– bioAffinity Technologies, (NASDAQ: BIAF, BIAFW), a biotechnology company that develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung, today announced publication of its research in...
by Dale Harrison | Sep 9, 2022 | Articles, News
San Antonio biotech goes public raising nearly $8M SEPTEMBER 9, 2022 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal Roughly eight years after its launch, San Antonio-based biotech bioAffinity...
